Showing 1 posts of 1 posts found.
Pfizer and GlaxoSmithKline are both handing back the rights to two drugs in April 2013 as part of the termination …
MHRA approves first lower-carbon beclometasone inhalers for asthma
Samsung Biologics launches bid to acquire peptide CDMO PolyPeptide
Novogenia breaks ground on personalised healthcare campus
InfectoPharm launches Polish operations with first hospital antibiotic
FibroFind appoints Lee Borthwick as CEO